Cargando…

High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion

Bio-aerosol dispersion via high-flow nasal cannula shows a similar risk to standard oxygen masks. High-flow nasal prongs with a surgical mask on the patient's face might benefit hypoxaemic COVID-19 patients without added risk for the environment. https://bit.ly/34p7Fyy

Detalles Bibliográficos
Autores principales:	Li, Jie, Fink, James B., Ehrmann, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163690/ https://www.ncbi.nlm.nih.gov/pubmed/32299867 http://dx.doi.org/10.1183/13993003.00892-2020

Ejemplares similares

High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
por: Li, Jie, et al.
Publicado: (2020)

High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
por: Elshof, Judith, et al.
Publicado: (2020)

Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion
por: Li, Jie, et al.
Publicado: (2021)

Standard pleural interventions are not high-risk aerosol generating procedures
por: Arnold, David T., et al.
Publicado: (2021)

High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU
por: Guy, Tiphaine, et al.
Publicado: (2020)

COVID-19: minimising risk to healthcare workers during aerosol-producing respiratory therapy using an innovative constant flow canopy
por: Adir, Yochai, et al.
Publicado: (2020)

High-Flow Aerosol-Dispersing versus Aerosol-Generating Procedures
por: Li, Jie, et al.
Publicado: (2020)

In vitro model for investigating aerosol dispersion in a simulated COVID-19 patient during high-flow nasal cannula treatment
por: McGrath, James A., et al.
Publicado: (2022)

Bronchodilator Delivery via High-Flow Nasal Cannula: A Randomized Controlled Trial to Compare the Effects of Gas Flows
por: Li, Jie, et al.
Publicado: (2021)

The Ratio of Nasal Cannula Gas Flow to Patient Inspiratory Flow on Trans-nasal Pulmonary Aerosol Delivery for Adults: An in Vitro Study
por: Li, Jie, et al.
Publicado: (2019)

Complications of nasal and pharyngeal swabs: a relevant challenge of the COVID-19 pandemic?
por: Föh, Bandik, et al.
Publicado: (2021)

Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with professional-collected nasal versus nasopharyngeal swab
por: Lindner, Andreas K., et al.
Publicado: (2021)

Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab
por: Lindner, Andreas K., et al.
Publicado: (2021)

High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
por: Dhooria, Sahajal, et al.
Publicado: (2022)

Is High-Flow Nasal Cannula Oxygen Therapy an Aerosol-Generating Medical Procedure?
por: Hamada, Satoshi, et al.
Publicado: (2021)

Is High-Flow Nasal Cannula Oxygen Therapy an Aerosol-Generating Medical Procedure?
por: Hamada, Satoshi, et al.
Publicado: (2021)

High-sensitive cardiac troponin after CPAP in obstructive sleep apnoea: the adjusted analytical change limit (adjACL) for small variations at low concentrations
por: Monneret, Denis
Publicado: (2022)

Is high-dose glucocorticoid beneficial in COVID-19?
por: Muthu, Valliappan, et al.
Publicado: (2021)

Screening for tuberculosis among high-risk groups attending London emergency departments: a prospective observational study
por: Gupta, Rishi K., et al.
Publicado: (2021)

Arterial hypertension and the risk of severity and mortality of COVID-19
por: Leiva Sisnieguez, Carlos Enrique, et al.
Publicado: (2020)

Reply: Is high-dose glucocorticoid beneficial in COVID-19?
por: Edalatifard, Maryam, et al.
Publicado: (2021)

Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation
por: Belli, Stefano, et al.
Publicado: (2020)

Risk factors for viral RNA shedding in COVID-19 patients
por: Fu, Yu, et al.
Publicado: (2020)

Short-term outcomes of COVID-19 and risk factors for progression
por: Long, Li, et al.
Publicado: (2020)

To compare the incomparable: COVID-19 pneumonia and high-altitude disease
por: Strapazzon, Giacomo, et al.
Publicado: (2020)

The high mental health burden of “Long COVID” and its association with on-going physical and respiratory symptoms in all adults discharged from hospital
por: Naidu, Sindhu B., et al.
Publicado: (2021)

Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support
por: Riera, Jordi, et al.
Publicado: (2022)

High-Flow Nasal Cannula for COVID-19 Patients: A Multicenter Retrospective Study in China
por: Duan, Jun, et al.
Publicado: (2021)

JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk
por: Mehta, Puja, et al.
Publicado: (2020)

COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
por: McAlinden, Kielan Darcy, et al.
Publicado: (2020)

The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients
por: Vicenzi, Marco, et al.
Publicado: (2020)

Humidification via high-flow nasal cannula oxygen therapy does not generate aerosols
por: Hamada, Satoshi, et al.
Publicado: (2021)

Assessment of dispersion of airborne particles of oral/nasal fluid by high flow nasal cannula therapy
por: Jermy, M. C., et al.
Publicado: (2021)

Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population
por: Taylor-Robinson, David C., et al.
Publicado: (2014)

Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with COPD and asthma: protocol for a randomised controlled trial
por: Li, Jie, et al.
Publicado: (2019)

A cuckoo COVID coincidence?
por: Chalmers, James D., et al.
Publicado: (2020)

Cardiovascular comorbidity and its impact on patients with COVID-19
por: Guan, Wei-jie, et al.
Publicado: (2020)

High-Flow Nasal Cannula Failure Odds Is Largely Independent of Duration of Use in COVID-19
por: Gershengorn, Hayley B., et al.
Publicado: (2022)

High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission
por: Agarwal, Arnav, et al.
Publicado: (2020)

Impact of Gas Flow and Humidity on Trans-Nasal Aerosol Deposition via Nasal Cannula in Adults: A Randomized Cross-Over Study
por: Alcoforado, Luciana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dikrptqh37q4ee21h8dgh63eoe